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Many drugs achieve their effects by modulating multiple targets. These targets are, however, often 
unknown and difficult to find among the thousands of gene products. Yet this knowledge could be of 
substantial value to future drug development, in particular for side effect prediction and drug 
repositioning. 
 
We propose a computational method tackling this target identification problem by the analysis of 
gene expression following drug treatment in the context of a functional protein association 
network. More specifically, genes are prioritized as potential targets based on the transcriptional 
response of functionally related genes. To this end, differential expression signals are diffused over 
the network either using a kernel-based random walk or on the basis of connectivity correlations 
between nodes. 
 
Both diffusion strategies were evaluated on 235 publicly available gene expression datasets for 
treatment with bioactive molecules having a known target. With AUC values of 91% and 92% 
respectively, the best results were obtained by a single-step symmetric normalized Laplacian kernel 
diffusion of moderated t-statistics and by a correlation-based diffusion of log2 ratios.  
 
The obtained AUC values indicate the predictive power of integrating experimental gene expression 
data with prior knowledge on protein interactions to identify the targets of a drug. 
